1. Home
  2. /
  3. Capabilities
  4. /
  5. Phase II-IV Clinical Trial...

Phase II-IV Clinical Trial Management

Vast Therapeutic Expertise, Global Reach, and Seamless Execution

Lambda Therapeutic Research specializes in facilitating Phase II-IV studies for investigational new drugs (INDs), biologics, and medical devices. With over two decades of clinical operations experience, we offer a solid foundation and a comprehensive array of services to navigate the complexities of multi-centric clinical programs across various therapeutic areas. Our services encompass the entire clinical trial lifecycle, from initial study feasibility and pre-site qualification to study initiation, patient recruitment, site management, and thorough study monitoring, incorporating Central Monitoring, Remote Monitoring, and on-site monitoring. 

0 +
Late Phase Studies
0 +
0 +

Lambda & Novum has enrolled 80000+ patients in various therapeutic categories and conducted over 265+ multicentric trials across different geographies with data submitted to all leading agencies including US FDA, EMEA, DCGI, ANVISA. 

Therapeutic Expertise:

Lambda specializes in assisting small and mid-sized biotech Companies focused on groundbreaking science, particularly in intricate and challenging disease areas. Our robust investigator network and expertise in Late Phase Clinical Trials for therapeutic areas such as oncology, dermatology, CNS, Psychiatry, musculoskeletal, rheumatology, ophthalmology, and more, make us well-positioned to address the challenges of late-stage drug development. Drawing upon extensive experience and proven expertise in these complex therapeutic domains, we bolster your team on the path to providing renewed hope for patients through the clinical journey.

No Data Found

Patient-Based PK Studies

With a proven track record, we accelerate patient-based PK studies across therapeutic areas, overcoming challenges with precision and innovation, backed by experience in over 50 studies across diverse indications.

  • Schizophrenia
  • Ovarian Cancer
  • Metastatic Breast Cancer and Colorectal Cancer
  • Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer
  • Solid Tumor, Advanced solid malignancies
  • Advanced Ovarian Cancer or Metastatic Breast Cancer
  • Pancreatic or Ovarian Cancer
  • Chronic Refractory Immune (Idiopathic) Thrombocytopenic Purpura
  • Iron Deficiency Anemia
  • Rheumatoid Arthritis / Psoriasis, Knee Osteoarthritis
  • Acute Myeloid Leukemia in Remission Phase
  • Chronic Myeloid Leukemia
  • Malignant Gliomas
  • Philadelphia chromosome positive Chronic Myeloid Leukemia
  • Glioblastoma Multiforme or Anaplastic Astrocytoma
  • Breast cancer or Colorectal Cancer
  • Moderate to Severe Atopic Dermatitis

Experience the Lambda Advantage

Lambda’s Phase II-IV Clinical Trial Management services offer a blend of experience, global reach, and disciplined execution. We empower your clinical trials with tailored solutions, propelling your product towards successful commercialization while ensuring utmost safety and efficiency. Trust Lambda to manage your trials with expertise and precision, meeting your unique objectives at every stage of development.

Experts from various fields such as medicine, pharmacy, biotechnology, and life sciences, ensuring a comprehensive approach to clinical trial management.

Streamlining the entire process from inception to commercialization.

Extensive experience in managing multi-centric clinical trials spanning diverse therapeutic areas, ensuring a global perspective in study execution.

Leveraging our extensive global site alliance network, we ensure efficient trial conduct and data collection across various regions.

Strong expertise in New Drug Delivery Systems (NDDS) and biosimilars, adding a strategic edge to your clinical development.

Proven track record in handling complex molecules across a wide range of therapeutic areas, bringing valuable insights to your trials.

We utilize a sophisticated and fully customizable Clinical Trial Management System (CTMS), seamlessly integrating every facet of the trial process. This technology allows for real-time data access, efficient communication, and informed decision-making.

Let's Unveil New Therapies Together

Connect with our experts to leverage our proven track record of clinical research excellence.